NYSE:MCK
McKesson Corporation Stock News
$543.30
+3.36 (+0.622%)
At Close: Apr 26, 2024
McKesson (MCK) Rises But Trails Market: What Investors Should Know
07:16pm, Friday, 26'th Apr 2024
In the closing of the recent trading day, McKesson (MCK) stood at $543.30, denoting a +0.62% change from the preceding trading day.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
10:55am, Friday, 26'th Apr 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
10:40am, Friday, 19'th Apr 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why McKesson (MCK) is a Strong Value Stock
10:46am, Monday, 01'st Apr 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
12:46pm, Thursday, 28'th Mar 2024
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
04:10pm, Wednesday, 27'th Mar 2024
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company wil
Here's Why You Should Hold McKesson (MCK) in Your Portfolio
10:16am, Friday, 22'nd Mar 2024
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
10:40am, Thursday, 07'th Mar 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing McKesson (MCK) Right Now?
10:46am, Wednesday, 28'th Feb 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
12:11pm, Tuesday, 27'th Feb 2024
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Here's Why McKesson (MCK) is a Strong Value Stock
10:41am, Tuesday, 20'th Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson: GLP-1 Contributed More Than 1/3 Of Growth
03:22am, Monday, 19'th Feb 2024
McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year gro
3 Attractive Medical Stocks to Buy After Earnings
04:56pm, Thursday, 08'th Feb 2024
Following their favorable quarterly results this week here are three intriguing healthcare stocks that investors will want to consider.
McKesson (MCK) Beats on Q3 Earnings, Raises FY24 EPS View
10:31am, Thursday, 08'th Feb 2024
McKesson's (MCK) third-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.
Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings
07:00pm, Wednesday, 07'th Feb 2024
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
